| Literature DB >> 20842494 |
Jasmine Tan-Kim1, Shawn A Menefee, Karl M Luber, Charles W Nager, Emily S Lukacz.
Abstract
INTRODUCTION AND HYPOTHESIS: The purpose of this study is to identify risk factors for mesh erosion in women undergoing minimally invasive sacrocolpopexy (MISC). We hypothesize that erosion is higher in subjects undergoing concomitant hysterectomy.Entities:
Mesh:
Year: 2010 PMID: 20842494 PMCID: PMC3025104 DOI: 10.1007/s00192-010-1265-3
Source DB: PubMed Journal: Int Urogynecol J ISSN: 0937-3462 Impact factor: 2.894
Fig. 1Mesh erosion rates in women undergoing minimally invasive sacrocolpopexy (MISC) using various techniques. PH post-hysterectomy (reference group), SCH supracervical hysterectomy, TVH total vaginal hysterectomy, VALSC vaginally assisted laparoscopic sacrocolpopexy (transvaginal placement of mesh), and VHLSC vaginal hysterectomy prior to laparoscopic sacrocolpopexy (laparoscopic placement of mesh). Asterisk Fisher's exact test
Univariate analysis of demographics, baseline characteristics, and concomitant procedures
| Variable | No mesh erosion( | Mesh erosion( |
|
|---|---|---|---|
| Age (years) | 60.7 ± 9.2 | 61.4 ± 5.9 | 0.707a |
| Gravity | 3.4 (3) | 2.8 (3) | 0.940b |
| Para | 2.9 (3) | 2.5 (3) | 0.695b |
| Weight (lbs) | 155.2 ± 24.8 | 147.2 ± 24.8 | 0.245a |
| Race | 0.912c | ||
| White | 80% | 74% | |
| Hispanic | 15% | 21% | |
| Asian | 4% | 5% | |
| AA | 1% | 0% | |
| Other | 1% | 0% | |
| Diabetes mellitus | 9% | 16% | 0.401d |
| Smoking | 0.341c | ||
| Current | 4% | 5% | |
| Past | 18% | 32% | |
| HRT/menopause | 0.394c | ||
| Premenopausal | 17% | 5% | |
| Menopause + HRT | 27% | 26% | |
| Menopause no HRT | 56% | 68% | |
| Preop Ba | 2.9 (3) | 2.9 (3) | 0.391b |
| Preop C | 1.0 (1) | 0.4 (0) | 0.562b |
| Preop Bp | 0.1 (−1) | −0.05 (0) | 0.387b |
| Prolapse stage | 2.8 (3) | 2.9 (3) | 0.558b |
| Postop Hgb | 10.9 ± 1.2 | 10.9 ± 0.8 | 0.901a |
| Surgery time (min) | 255.7 ± 71.0 | 262.3 ± 67.8 | 0.512 a |
| Anterior repair | 2% | 5% | 0.349d |
| Paravaginal repair | 9% | 16% | 0.401d |
| Posterior repair | 15% | 32% | 0.075c |
| Mid-urethral sling | 46% | 47% | 0.920c |
| Hysterectomy status | 0.001c | ||
| Post-hysterectomy | 62% | (5/19) 26% | |
| SCH | 12% | (1/19) 5% | |
| TVH | 26% | (13/19) 68% |
HRT Hormone replacement therapy—systemic, Hgb Hemoglobin SCH Supracervical hysterectomy, TVH Total vaginal hysterectomy
aContinuous data summarized as mean ± SD and compared between groups with the use of Mann–Whitney U test(<30 cases, central limit theorem)
bNon-parametric continuous data summarized as mean (median) and compared with the use of the Wilcoxon's rank test
cCategorical data summarized as frequency (%) and compared between groups with the use of the Χ 2 test
dFisher's Exact test
Multivariable logistic regression model for posterior repair and type of hysterectomy
| Variable | Exp (B) odds ratio | 95% CI for Exp (B) |
|
|---|---|---|---|
| Constant | 0.043 | ||
| Posterior repair | 1.88 | 0.62–5.70 | 0.268 |
| Refa = Post-hysterectomy | |||
| SCH | 0.99 | 0.11–9.03 | 0.996 |
| TVH | 5.67 | 1.88–17.10 | 0.002 |
aReference group
SCH supracervical hysterectomy, TVH total vaginal hysterectomy
Fig. 2Only 3 (20%) of the 15 erosions resolved with estrogen therapy alone. A total of 10 (53%) of the 19 erosions required surgical management for definitive treatment and all 10 of these erosions resolved after surgery. Of the 19 subjects, five (3 + 2; 26%) ultimately opted for expectant management without further follow-up at the time of this review